Home » Volumes » Volume 18 July/September 1985 » Auto-immunity in Chagas’ disease: fact or fancy? cause or consequence?

Auto-immunity in Chagas’ disease: fact or fancy? cause or consequence?

Felipe Kierszenbaum

Department of Microbiology and Public Health Michigan State Üniversity East Lansing, Michigan 48824, USA

DOI: 10.1590/S0037-86821985000300002

Full text available only in PDF format.

Texto completo disponível apenas em PDF.




1. Brener Z. Immunity to Trypanosoma cruzi. Advances in Parasitology 18: 247-292, 1980.         [ Links ]

2. Bretana A, 0’Daly JA. Uptake of fetal proteins by Trypanosoma cruzi. Immunofluorescence and ultrastructural studies. International Journal of Parasitology 6: 379-386, 1976.         [ Links ]

3. Chagas C. Nova trypanomiase humana. Estudos sobre a morphologia e o ciclo evolutivo da Schizotrypanum cruzin. gen., n. sp., agente etiologico de nova entidade mórbida do homem. Memórias do Instituto Oswaldo Cruz 1:159-218, 1909.         [ Links ]

4. Cossio PM, Diez C, Szarfman A, Kreutzer E, Candiolo B, Arana, RM. Chagasic cardiopathy, Demonstration of a serum gamma globulin factor which reacts with endocardium and vascular structures. Circulation 49:13- 21, 1974.         [ Links ]

5. Khoury EL, Diez C, Cossio PM, Arana RM. Heterophil nature of EVI antibody and Trypanosoma cruzi infection. Clinical and Experimental Immunology 27: 283-288, 1983.         [ Links ]

6. Ribeiro dos Santos R, Hudson L. Denervation and the immune response in mice infected with Trypanosoma cruzi. Clinical and Experimental Immunology 44:349- 354, 1981.         [ Links ]

7. Santos-Buch CA. Auto-immunity and Chagas’ disease: demonstration of a common immunogen of heart and Trypanosoma cruzi. In: Miescher P, Bolis A, Gorini S, Lambo TA, Nossal GJV & Torrigiani G (eds) First Symposium on Organ-specific Auto-immunity, The Menarini Series on Immunopathology. Schwabe & Co, Baselpp. 101-119, 1978.         [ Links ]

8. Santos-Buch CA, Teixeira ARL. The immunology of experimental Chagas’ disease. III. Rejection of allogenic heart cells in vitro. Journal of Experimental Medicine 140:38-53, 1974.         [ Links ]

9. Schmunis GA, Cossio, PM, Szarfman A, Coarasa L, Arana RM. Tissue-reacting antibodies (EVI antibodies) in Nifiirtimox-treated patients with Chagas’ disease. Journal of Infectious Diseases 138:401-404, 1978.         [ Links ]

10. Szarfman A, Cossio PM, Diez C, Arana RM, Sadun E. Antibodies against endocardium, vascular structures and interstitium of striated muscle that cross-react with T. cruzi and T. rhodesiense. Journal of Parasitology 60: 1024, 1974.         [ Links ]

11. Szarfman A, Khoury E, Cossio PM, Arana RM, Kagan, IG. Investigation of the EVI antibody in parasitic diseases other than American trypanosomiasis. An anti- skeletal muscle antibody in leishmaniasis. American Journal of Tropical Medicine and Hygiene 24:19-24, 1975.         [ Links ]

12. Szarfman A, Terranova VP, Rennard SI, Foidart J-M, Lima MDF, Scheinman, JI, Martin GR. Antibodies to laminin in Chagas’ disease. Journal of Experimental Medicine 155:1161-1171, 1982.         [ Links ]

13. Teixeira ARL. Immunoprophylaxis against Chagas’ disease. Advances in Experimental Medicine and Biology 93:243-280, 1977.         [ Links ]

14. Teixeira ARL, Teixeira G, Macêdo V, Prata A. Trypanosoma cruzi-sensitized T-lymphocyte mediated 51Cr-release from human heart cells in Chagas’ disease. American Journal of Tropical Medicine and Hygiene 27:1097-1107, 1978.         [ Links ]

15. Wood JN, Hudson L, Jessell TM, Yamamoto M. A monoclonal antibody defining antigenic determinants on subpopulations of mammalian neurones and Trypanosoma cruzi parasites. Nature (London) 296:34-38, 1982.         [ Links ]